XKRX
100120
Market cap195mUSD
Oct 08, Last price
30,300.00KRW
1D
2.89%
1Q
27.58%
Jan 2017
-49.33%
IPO
9.39%
Name
Vieworks Co Ltd
Chart & performance
P/E
11.93
P/S
1.10
EPS
2,539.59
Div yield, %
1.98%
Shrs. gr., 5y
-0.42%
Rev. gr., 5y
8.35%
Revenues
239.34b
+7.37%
Net income
21.97b
+3.17%
CFO
37.19b
+4.52%
Dividend
Dec 29, 2025600 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vieworks Co., Ltd. is dedicated to the development, manufacturing, and sale of comprehensive imaging systems and solutions. The company provides X-ray detectors alongside image processing technologies utilized across numerous fields, including general and veterinary radiography systems, dental and surgical C-arm systems, radiography and fluoroscopy setups, and industrial inspection instruments. Beyond its X-ray offerings, Vieworks also produces industrial-grade cameras and specialized bio-imaging systems, which encompass in vivo imaging solutions under the VISQUE brand. Founded in 1999, the organization was formerly known as Raysis Co., Ltd. before officially changing its name to Vieworks Co., Ltd. in November 2006. The company maintains its headquarters in Anyang-si, South Korea.
Key people
Su Gil Lee
Assistant Managing Director · since 2011
Cheol Sang Lee
Internal Auditor
Gyeong Yeol Seo
Assistant Managing Director · since 2011
Hyeon Seok Jang
Director · since 2019
Chief Executive Officer, Director · since 2002
Beom Gon Kim
Managing Director · since 2010
Gyeong Suk Hyun
Non-Executive Independent Director · since 2019
Jae Wun Jung
Non-Executive Independent Director · since 2010
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||